HUTCHMED (China) Limited (0013.HK)

HKD 23.0

(-0.22%)

Long Term Debt Summary of HUTCHMED (China) Limited

  • HUTCHMED (China) Limited's latest annual long term debt in 2023 was 51.04 Million USD , up 119.09% from previous year.
  • HUTCHMED (China) Limited's latest quarterly long term debt in 2024 Q1 was 59.23 Million USD , up 15.45% from previous quarter.
  • HUTCHMED (China) Limited reported annual long term debt of 23.3 Million USD in 2022, up 225.37% from previous year.
  • HUTCHMED (China) Limited reported annual long term debt of 7.16 Million USD in 2021, down -78.25% from previous year.
  • HUTCHMED (China) Limited reported quarterly long term debt of 55.63 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • HUTCHMED (China) Limited reported quarterly long term debt of 40.14 Million USD for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of HUTCHMED (China) Limited (2023 - 2005)

Historical Annual Long Term Debt of HUTCHMED (China) Limited (2023 - 2005)

Year Long Term Debt Long Term Debt Growth
2023 51.04 Million USD 119.09%
2022 23.3 Million USD 225.37%
2021 7.16 Million USD -78.25%
2020 32.92 Million USD 10.24%
2019 29.86 Million USD 11.7%
2018 26.73 Million USD 4518.13%
2017 579 Thousand USD -97.84%
2016 26.83 Million USD -0.35%
2015 26.92 Million USD 0.0%
2014 26.92 Million USD 0.0%
2013 - USD -100.0%
2012 26.92 Million USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 145.52 Thousand USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%

Peer Long Term Debt Comparison of HUTCHMED (China) Limited

Name Long Term Debt Long Term Debt Difference
Pak Fah Yeow International Limited 2.07 Million HKD -2362.568%
Grand Pharmaceutical Group Limited 990.02 Million HKD 94.844%
Extrawell Pharmaceutical Holdings Limited 117.12 Million HKD 56.415%
Wai Yuen Tong Medicine Holdings Limited 276.2 Million HKD 81.517%
Qianhai Health Holdings Limited - HKD -Infinity%
Lee's Pharmaceutical Holdings Limited 70.63 Million HKD 27.729%
Essex Bio-Technology Limited 36.05 Million HKD -41.58%
Tongfang Kontafarma Holdings Limited 12.8 Million HKD -298.789%
PuraPharm Corporation Limited 81.09 Million HKD 37.049%
SSY Group Limited 1.94 Billion HKD 97.379%
JBM (Healthcare) Limited 43.8 Million HKD -16.55%
Jacobson Pharma Corporation Limited 592.2 Million HKD 91.38%
China Resources Pharmaceutical Group Limited 16.61 Billion HKD 99.693%